Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011

Pediatric Dermatology

Volumn 31, Issue 2, 2014, Pages 159-162

  Kelly Mancuso, Geraldine ^a   Kopelan, Brett ^a   Azizkhan, Richard G ^b   Lucky, Anne W ^b  

^a Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; EPIDERMOLYSIS BULLOSA; HEALTH EDUCATION; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES; EPIDEMIOLOGY; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; FEMALE; INCIDENCE; MALE; MORTALITY; RETROSPECTIVE STUDY;

EPIDERMOLYSIS BULLOSA, JUNCTIONAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 84895926886     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12157     Document Type: Article

References (15)

1. Salas-Alanis JC, Cepeda-Valdes R, Mellerio JE, et al. Progress in epidermolysis bullosa: summary of a workshop in CILAD-2010. Int J Dermatol 2012; 51: 682-687.
2. Fine JD, Eady RAJ, Bauer EA,. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 931-950.
3. Fine JD, Mellerio JE,. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 2009; 61: 367-384.
4. Fine JD, Mellerio JE,. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 2009; 61: 387-402.
5. Yuen WY, Lemmink HH, van Dijk-Bos KK, et al. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands. Br J Dermatol 2011; 165: 1314-1322.
6. Fine JD, Johnson LB, Suchindran C, et al. The epidemiology of inherited epidermolysis bullosa. In:, Fine JD, Bauer EA, McGuire J, Moshell A, eds. Epidermolysis bullosa. Clinical, epidemiologic, and laboratory findings of the national epidermolysis bullosa registry. Baltimore, MD: Johns Hopkins University Press, 1999: 101-113.
7. Castori M, Floriddia G, De Luca N, et al. Herlitz junctional epidermolysis bullosa: laminin-5 mutational profile and carrier frequency in the Italian population. Br J Dermatol 2008; 158: 38-44.
8. Laimer M, Lanschuetzer CM, Diem A,. Herlitz junctional epidermolysis bullosa. Dermatol Clin 2010; 28: 55-60.
9. Kho Y, Rhodes LM, Robertson SJ, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol 2010; 146: 635-640.
10. Yan EG, Paris JJ, Ahluwalia J, et al. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa. J Perinatol 2007; 27: 307-311.
11. Siprashvili Z, Nguyen NT, Bezchinsky MY, et al. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther 2010; 21: 1299-1310.
12. Di Nunzio F, Maruggi G, Mavilio F, et al. Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors. Mol Ther 2008; 16: 1977-1985.
13. Remington J, Wang X, Hou Y, et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 2009; 17: 26-33.
14. Tolar J, Xia L, Blazar B, et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011; 131: 848-856.
15. Conget P, Rodriguez F, Yubero M, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010; 12: 429-431.